These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 5375104)
1. Hemofil and other factor VIII concentrates. Med Lett Drugs Ther; 1969 Nov; 11(23):96. PubMed ID: 5375104 [No Abstract] [Full Text] [Related]
2. Recent trends in the management of hemophilia. Dubey SM; Agarwal KN Indian Pediatr; 1974 May; 11(5):359-65. PubMed ID: 4426664 [No Abstract] [Full Text] [Related]
3. Use of blood products and factor concentrates for coagulation therapy. Fritsma MG Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192 [TBL] [Abstract][Full Text] [Related]
4. [Concentrated antihemophilic globulin in the treatment of hemorrhagic syndromes]. Baklaja F; Cvetković V; Stajić M; Krivokapić L Bilt Hematol Transfuz; 1976; 4(3):61-6. PubMed ID: 1008799 [TBL] [Abstract][Full Text] [Related]
5. Congenital combined deficiency of factor V and factor 8. A case report and the effect of transfusion of normal plasma and hemophilic blood. Saito H; Shioya M; Koie K; Kamiya T; Katsumi O Thromb Diath Haemorrh; 1969 Nov; 22(2):316-25. PubMed ID: 5380951 [No Abstract] [Full Text] [Related]
6. [Substitution therapy with factor 8 and factor IX preparations]. Landbeck G Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465 [No Abstract] [Full Text] [Related]
7. Transfusion therapy in congenital coagulopathies. Lusher JM Hematol Oncol Clin North Am; 1994 Dec; 8(6):1167-80. PubMed ID: 7860443 [TBL] [Abstract][Full Text] [Related]
8. [Substitution therapy of coagulopathies]. Beeser H; Egli H Infusionstherapie (1973); 1974 Aug; 1(6):447-53. PubMed ID: 4466806 [No Abstract] [Full Text] [Related]
10. Therapy of hereditary disorders of blood coagulation. Breckenridge RT; Ratnoff OD Mod Treat; 1968 Jan; 5(1):39-60. PubMed ID: 4870179 [No Abstract] [Full Text] [Related]
11. The management of patients with bleeding disorders. Wyld PJ; Dawson KP N Z Med J; 1984 Feb; 97(750):118-9. PubMed ID: 6424072 [No Abstract] [Full Text] [Related]
12. The management of factor VIII inhibitors in non-hemophilic patients. Green D Prog Clin Biol Res; 1984; 150():337-52. PubMed ID: 6431438 [TBL] [Abstract][Full Text] [Related]
13. [Statistic considerations in the treatment of patients with coagulation disorders: 2 methods of approach]. Moro GF; Campolongo F Riv Ital Stomatol; 1983; 52(7-8):589-92. PubMed ID: 6236541 [No Abstract] [Full Text] [Related]
14. Management of the hereditary coagulation disorders. Mason DY; Ingram GI Semin Hematol; 1971 Apr; 8(2):158-88. PubMed ID: 5313347 [No Abstract] [Full Text] [Related]
15. Comparison of factor VIII and prothrombin complex concentrates in the treatment of inhibitor patients. Prentice CR Prog Clin Biol Res; 1984; 150():197-206. PubMed ID: 6431428 [No Abstract] [Full Text] [Related]
16. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor]. Klukowska A; Zieleniewska B Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036 [TBL] [Abstract][Full Text] [Related]
17. The physiologic basis for therapy of classic hemophilia (factor 8 deficiency) and related disorders. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med; 1967 Oct; 67(4):856-82. PubMed ID: 5299081 [No Abstract] [Full Text] [Related]
18. [Clinical studies in therapy using coagulation-active plasma concentrates]. Perlick E Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):300-15. PubMed ID: 4195274 [No Abstract] [Full Text] [Related]
19. [Experiences in the use of Cohn's fraction I]. Beeser H; Egli H Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):349-56. PubMed ID: 4195281 [No Abstract] [Full Text] [Related]
20. [Current status of the preparation and use of antihemophilic fractions in France. (Their use in surgery in hemophilia)]. Ménaché D; Josso F; Steinbuch M; Soulier JP Transfusion (Paris); 1966; 9(3):237-44. PubMed ID: 5969559 [No Abstract] [Full Text] [Related] [Next] [New Search]